CDC Releases New Resources for Multisystem Inflammatory Syndrome in Children

Published: 09/23/2021

  • Centers for Disease Control and Prevention
Relevant To:
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care

The Centers for Disease Control and Prevention (CDC) has developed and tested new materials to support healthcare professionals (HCPs) in diagnosing and treating multisystem inflammatory syndrome in children (MIS-C). MIS-C is a rare, but serious complication associated with COVID-19 in children, adolescents, and young adults where multiple organ systems can become inflamed. The cause of MIS-C has not been determined, but many children with MIS-C have had the virus that causes COVID-19, or have b

Sign Up for Free Trial